Improving Development of and Patient Access to Early Phase Pediatric Cancer Clinical Trials |
Seattle Children’s Hospital and Regional Medical Center / Russ Geyer |
Phase I/II Infrastructure Grants |
2010 |
Washington |
Identification of the Molecular Targets of MLL Translocation-Based Childhood Leukemia |
Stowers Institute for Medical Research / Ali Shilatifard |
Innovation Grants |
2010 |
Missouri |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research / Andrew Napper |
Innovation Grants |
2010 |
Delaware |
Understanding the Role of a Novel Hereditary Cancer Gene |
University of Texas Health Science Center at San Antonio / Patricia Dahia |
Innovation Grants |
2010 |
Texas |
Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Identification of Novel Treatment Targets by Exploring the Interaction of Rhabdomyosarcoma-Associated Oncogenes with Cellular Context in a Mouse Model of Rhabdomyosarcoma |
Dana-Farber Cancer Institute / Simone Hettmer |
Young Investigator Grants |
2010 |
Massachusetts |
Center for Pediatric T Cell Therapy (CEPET) |
Baylor College of Medicine / Cliona Rooney |
Phase I/II Infrastructure Grants |
2010 |
Texas |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia |
Stanford University / Kara Davis |
Young Investigator Grants |
2010 |
California |
Long-Term Morbidity in Survivors of Childhood Cancer with Down Syndrome |
University of California San Francisco / Shannon Raber |
Nurse Researcher Grants |
2010 |
California |